drugs of abuse Flashcards
opioids, reinforcing effects, NE involved, acute toxicities and tx, tolerance and dependence, withdrawal tx for withdrawal, relapse prevention.
agonist at u opioid receptor [Gi/o], euphoria,sedation
respiratory depression miosis->death arrtythmias, convulsions–> Tx=naloxone (IV/SC). tolerance develops quickly, but not miosis or constipation, dependence develops rapidly, withdrawal rarley life threatening, irritibility, insomnia, tachycardia, cramps diarrhea HTN, muscle aches. Tx=clonidine, methadone, relapse- buprenorphin, naloxone, naltrexone
CNS depressants reinforcing effects, NE involved, acute toxicities and tx, tolerance and dependence, withdrawal tx for withdrawal, relapse prevention.
ethanol, Benzos, Barbiturates. anxiolysis, sedation, loss of inhibition. respiratory depression, coma, death (rare w/ BZD). Tx- supportive for etoh and barbs, Flumazenil for BZD
tolerance Barb>etoh>BDZ. dependent within weeks.
wothdrawal- mortality risk due to seizures Tx- use benzo and dose taper. relapse- acamprosate naltrezone, disulfiram
CNS stimulants reinforcing effects, NE involved, acute toxicities and tx, tolerance and dependence, withdrawal tx for withdrawal, relapse prevention.
cocaine, amphetamins, methamphetamine, methylphenidate. euphoria, fatigue, arousal and confidence, apetite suppression. SNS overactivity w/ increase HR BP temp chest pain arrhythmias, mi, paranoid psychosis Tx- CV support, vasodilatros BDZ for agitation and seizures, tolerance to euphoria anorexia, hyperthermia, SUPERSENSITIVITY to paranoia, dependence is arguable, withdrawal, sleepiness, fatigue, depression, hyperphagia, craving. relapse- largely behavioral
nicotine reinforcing effects, NE involved, acute toxicities and tx, tolerance and dependence, withdrawal tx for withdrawal, relapse prevention.
nicotinic cholinergic receptor agonist, increased alertness. acute tox rare, unless ingested by children, Tx CV support emetics, gastric lavage charcoal. tolerance to subjective effects and nausea, moderate dependence. withdrawal- irritibility, hostility, anxiety, increase appetite, weight gain
relapse-nicotine replacement, buproprion, varenicline
hallucinogens reinforcing effects, NE involved, acute toxicities and tx, tolerance and dependence, withdrawal tx for withdrawal, relapse prevention.
altered sensory perception hallucinations intense arousal, mood elevation (MDMA-insight and selfknowledge enhanced). severe anxiety, intense depression visual distrubances (MDMA-increase ADH–>hyponatremic)
marijuana reinforcing effects, NE involved, acute toxicities and tx, tolerance and dependence, withdrawal tx for withdrawal, relapse prevention.
euphoria, mellowness, changes in perception, mood, motivation. minimal possible anxiety impaired coordination and tracking behavior acute psychosis. tolarance develops rapidly and dissapears rapidly. abuse potential moderate, withdrawal not clinically significant due to long halflife, mild symptoms. Tx none
anticholinergics reinforcing effects, NE involved, acute toxicities and tx, tolerance and dependence, withdrawal tx for withdrawal, relapse prevention.
y
ethanol MOA
increases GABA, inhibit GLU-NMDA
BZD MOA
Increases Gaba channel in presence of GABA
Barbiturates
Increases GABA function with or w/o GABA, inhibits GLU AMPA
Cocaine
inhibits monamine reuptake transporters
amphetamine, methylphenidate, methamphetamine
stimulate monoamine release
Indoleamines (LSD, Psilocybin, bufotenine)
partial agonist at 5HT2 receptors
Phenylethylamines (MDMA,Mescaline)
partial agonist at 5HT2 + DA relaseing
Phenylcyclidine, katamine, NO, Dextromethorphan
GLU NMDA antagonist